These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

576 related items for PubMed ID: 24477328

  • 61. Pharmacokinetics/Pharmacodynamics of Peptide Deformylase Inhibitor GSK1322322 against Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus in Rodent Models of Infection.
    Hoover J, Lewandowski T, Straub RJ, Novick SJ, DeMarsh P, Aubart K, Rittenhouse S, Zalacain M.
    Antimicrob Agents Chemother; 2016 Jan; 60(1):180-9. PubMed ID: 26482300
    [Abstract] [Full Text] [Related]

  • 62. Gemifloxacin once daily for 7 days compared to amoxicillin/clavulanic acid thrice daily for 10 days for the treatment of community-acquired pneumonia of suspected pneumococcal origin.
    Léophonte P, File T, Feldman C.
    Respir Med; 2004 Aug; 98(8):708-20. PubMed ID: 15303634
    [Abstract] [Full Text] [Related]

  • 63. Pharmacodynamic target attainment potential of azithromycin, clarithromycin, and telithromycin in serum and epithelial lining fluid of community-acquired pneumonia patients with penicillin-susceptible, intermediate, and resistant Streptococcus pneumoniae.
    Noreddin AM, El-Khatib WF, Aolie J, Salem AH, Zhanel GG.
    Int J Infect Dis; 2009 Jul; 13(4):483-7. PubMed ID: 19046911
    [Abstract] [Full Text] [Related]

  • 64. The pattern of micro-organisms and the efficacy of new macrolide in acute lower respiratory tract infections.
    Soepandi P, Mangunnegoro H, Yunus F, Gunawan J.
    Respirology; 1998 Jun; 3(2):113-7. PubMed ID: 9692520
    [Abstract] [Full Text] [Related]

  • 65. Efficacy and safety of azithromycin versus benzylpenicillin or erythromycin in community-acquired pneumonia.
    Bohte R, van't Wout JW, Lobatto S, Blussé van Oud Alblas A, Boekhout M, Nauta EH, Hermans J, van den Broek PJ.
    Eur J Clin Microbiol Infect Dis; 1995 Mar; 14(3):182-7. PubMed ID: 7614957
    [Abstract] [Full Text] [Related]

  • 66. Penicillin resistance not a factor in outcome from invasive Streptococcus pneumoniae community-acquired pneumonia in adults when appropriate empiric therapy is started.
    Mufson MA, Chan G, Stanek RJ.
    Am J Med Sci; 2007 Mar; 333(3):161-7. PubMed ID: 17496734
    [Abstract] [Full Text] [Related]

  • 67.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 68. [Efficacy and safety of twice-daily administration of CTDR].
    Ogata H.
    Jpn J Antibiot; 2001 May; 54 Suppl B():98. PubMed ID: 12638156
    [No Abstract] [Full Text] [Related]

  • 69. Efficacy of β-Lactam-plus-Macrolide Combination Therapy in a Mouse Model of Lethal Pneumococcal Pneumonia.
    Yoshioka D, Kajiwara C, Ishii Y, Umeki K, Hiramatsu K, Kadota J, Tateda K.
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6146-54. PubMed ID: 27480866
    [Abstract] [Full Text] [Related]

  • 70. The efficacy of high-dose penicillin for community-acquired pneumonia diagnosed by pneumococcal urine antigen test.
    Oka H, Ueda A, Watanuki Y, Tsukiji J, Kuroda H, Akashi S, Hirai Y, Fuyuki T, Kaneko T, Ishigatsubo Y.
    J Infect Chemother; 2009 Apr; 15(2):108-12. PubMed ID: 19396521
    [Abstract] [Full Text] [Related]

  • 71. Efficacy and safety of azithromycin 1 g once daily for 3 days in the treatment of community-acquired pneumonia: an open-label randomised comparison with amoxicillin-clavulanate 875/125 mg twice daily for 7 days.
    Paris R, Confalonieri M, Dal Negro R, Ligia GP, Mos L, Todisco T, Rastelli V, Perna G, Cepparulo M.
    J Chemother; 2008 Feb; 20(1):77-86. PubMed ID: 18343748
    [Abstract] [Full Text] [Related]

  • 72. Cefditoren pivoxil versus cefpodoxime proxetil for community-acquired pneumonia: results of a multicenter, prospective, randomized, double-blind study.
    van Zyl L, le Roux JG, LaFata JA, Volk RS, Palo WA, Flamm R, Hom RC.
    Clin Ther; 2002 Nov; 24(11):1840-53. PubMed ID: 12501878
    [Abstract] [Full Text] [Related]

  • 73.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 74. A comparison of the efficacy, tolerability and safety of azithromycin and co-amoxiclav in the treatment of sinusitis in adults.
    Clement PA, de Gandt JB.
    J Int Med Res; 1998 Nov; 26(2):66-75. PubMed ID: 9602984
    [Abstract] [Full Text] [Related]

  • 75. [Clinical and bacteriological evaluation of ceftriaxone (CTRX) dosed once daily in children with community-acquired pneumonia].
    Toyonaga Y, Kanemura H, Kitano M, Mitsui Y, Ishihara T, Hoshiai M, Ohno R.
    Jpn J Antibiot; 1999 Apr; 52(4):322-32. PubMed ID: 10396689
    [Abstract] [Full Text] [Related]

  • 76. Efficacy of telithromycin in community-acquired pneumonia caused by pneumococci with reduced susceptibility to penicillin and/or erythromycin.
    van Rensburg DJ, Fogarty C, Kohno S, Dunbar L, Rangaraju M, Nusrat R.
    Chemotherapy; 2005 Jul; 51(4):186-92. PubMed ID: 15980629
    [Abstract] [Full Text] [Related]

  • 77. Population pharmacokinetics of oral levofloxacin 500 mg once-daily dosage in community-acquired lower respiratory tract infections: results of a prospective multicenter study in China.
    Zhang J, Xu JF, Liu YB, Xiao ZK, Huang JA, Si B, Sun SH, Xia QM, Wu XJ, Cao GY, Shi YG, Zhang YY.
    J Infect Chemother; 2009 Oct; 15(5):293-300. PubMed ID: 19856067
    [Abstract] [Full Text] [Related]

  • 78. Pneumococcal macrolide resistance--myth or reality?
    Amsden GW.
    J Antimicrob Chemother; 1999 Jul; 44(1):1-6. PubMed ID: 10459803
    [Abstract] [Full Text] [Related]

  • 79. The Effect of Macrolide Resistance on the Presentation and Outcome of Patients Hospitalized for Streptococcus pneumoniae Pneumonia.
    Cilloniz C, Albert RK, Liapikou A, Gabarrus A, Rangel E, Bello S, Marco F, Mensa J, Torres A.
    Am J Respir Crit Care Med; 2015 Jun 01; 191(11):1265-72. PubMed ID: 25807239
    [Abstract] [Full Text] [Related]

  • 80. Once-daily azithromycin for 3 days compared with clarithromycin for 10 days for acute exacerbation of chronic bronchitis: a multicenter, double-blind, randomized study.
    Swanson RN, Lainez-Ventosilla A, De Salvo MC, Dunne MW, Amsden GW.
    Treat Respir Med; 2005 Jun 01; 4(1):31-9. PubMed ID: 15725048
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.